97
Views
13
CrossRef citations to date
0
Altmetric
Perspectives

Perspective on the Rezūm® System: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapy

&
Pages 71-80 | Published online: 27 Apr 2017

References

  • KohJSChoKJKimHSKimJCTwelve-month medication persistence in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaInt J Clin Pract201468219720224372906
  • CindoloLPirozziLFanizzaCDrug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort studyEur Urol201568341842525465970
  • CindoloLPirozziLSountoulidesPPatient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?BMC Urol2015159610226391357
  • NicholMBKnightTKWuJBarronRPensonDFEvaluating use patterns of and adherence to medications for benign prostatic hyperplasiaJ Urol200918152214222119296986
  • KaplanSNaslundMPublic, patient, and professional attitudes towards the diagnosis and treatment of enlarged prostate: a landmark national US surveyInt J Clin Pract200660101157116516942587
  • EmbertonMMarbergerMde la RosetteJUnderstanding patient and physician perceptions of benign prostatic hyperplasia in Europe: the Prostate Research on Behaviour and Education (PROBE) SurveyInt J Clin Pract2008621182618028388
  • JepsenJVBruskewitzRCComprehensive patient evaluation for benign prostatic hyperplasiaUrology1998514A suppl13189586591
  • MalaebBSYuXMarshall McBeabAElliottSNational trends in surgical therapy for benign prostatic hyperplasia in the United States (2000–2008)Urology20127951111111722546389
  • DixonCMCedanoERMynderseLATransurethral convection water vapor as a treatment for lower urinary tract symptomology due to benign prostatic hyperplasia using the Rezūm® system: evaluation of acute ablative capabilities in the human prostateRes Rep Urol20157131825674555
  • American Urological AssociationAmerican Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH)2010 Available from: http://www.auanet.org/common/pdf/education/clinical-guidance/Benign-Prostatic-Hyperplasia.pdfAccessed February 20, 2017
  • RoehrbornCGGangeSNGittelmanMCConvective water vapor energy (WAVE) ablation therapy: durable two-year results and prospective blinded crossover study for treatment of lower urinary tract symptoms due to benign prostatic hyperplasiaJ Urol2017 In press 2017
  • GjengstøPHalvorsenOJAkslenLABenign growth of different prostate zones in aging men with slightly elevated PSA in whom prostate cancer has been excluded: a prospective study of 510 menUrology200362344745012946744
  • McLaughlinPWTroyerSBerriSFunctional anatomy of the prostate: implications for treatment planningInt J Radiat Oncol Biol Phys200563247949116168840
  • DixonCMCedanoERPacikDTwo-year results after convective water vapor energy treatment of symptomatic benign prostatic hyperplasiaRes Rep Urol2016820721627921028
  • KangDHLeeJYHahYSChungDYLeeDHChoKSCorrelation of prostatic urethral angle with the severity of urinary symptom and peak flow rate in men with small prostate volumePLoS One20149819
  • KuJHKoDWChoJYOhSJCorrelation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptomsUrology20107561467147119962734
  • MynderseLAHansonDRobbRARezūm system water vapor treatment for lower urinary tract symptoms/benign prostatic hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional renderingsUrology201586112212725987496
  • DixonCMCedanoERPacikDEfficacy and safety of Rezūm system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasiaUrology20158651042104726216644
  • McVaryKTGangeSNGittelmanMCMinimally invasive prostate convective water vapor energy (WAVE) ablation: a multicenter, randomized, controlled study for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasiaJ Urol201619551529153826614889
  • BarryMJWillifordWOChangYBenign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?J Urol19951545177017747563343
  • RoehrbornCGWilsonTHBlackLKQuantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trialJ Urol201218751732173822425127
  • McVaryKTGangeSNGittelmanMCErectile and ejaculatory function preserved with convective water vapor energy treatment of LUTS secondary to BPH: randomized controlled studyJ Sex Med201636924933
  • EganKBBurnettALMcVaryKTThe co-occurring syndrome—coexisting erectile dysfunction and benign prostatic hyperplasia and their clinical correlates in aging men: results from the National Health and Nutrition Examination SurveyUrology201586357058026210004
  • RosenRCAllenKRNiXAraujoABMinimal clinically important differences in the erectile function domain of the International Index of Erectile Function ScaleEur Urol20116051010101621855209
  • GuptaNKöhlerTSMcVaryKTConvective radiofrequency water vapor energy ablation (Rezūm®) effectively treats lower urinary tract symptoms due to benign prostatic enlargement regardless of obesity while preserving erectile and ejaculatory functionJ Urol2017197Suppl 4e609
  • GuptaNHollandBDelfinoKConvective radiofrequency water vapor energy prostate ablation (Rezūm®) effectively treats urinary retentionJ Urol2017197Suppl 4e337